Personalized medicine lecture open to the public May 20
Ciechanover speaks about "The Revolution of Personalized Medicine -- Are we Going to Cure All Diseases, and at What Price?" In 2004, he and his collaborators -- Avram Hershko, MD, PhD, and Irwin Rose, PhD -- received the Nobel Prize in Chemistry for the discovery of ubiquitin mediated protein degradation that revolutionized today‘s approach to treating cancer and that created new pathways to develop more effective therapies for neurodegenerative disorders and other genetic diseases.
Ciechanover is distinguished research professor of the Cancer and Vascular Biology Research Center, The Rappaport Faculty of Medicine and Research Institute at the Technion, Israel Institute of Technology in Haifa, Israel.